Trials / Completed
CompletedNCT02241759
Study of the Electrocardiographic Effects of TA-8995
A Phase I, Single-Centre, Randomised, Placebo and Positive- Controlled, Parallel-Group Study of the Electrocardiographic Effects of TA-8995 in Healthy Male and Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 136 (actual)
- Sponsor
- Xention Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A study in healthy males and females to see if a high single dose of TA-8995 has an effect on the ECG QTcF interval.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TA-8995 | |
| DRUG | Moxifloxacin | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2014-11-01
- Completion
- 2014-12-01
- First posted
- 2014-09-16
- Last updated
- 2015-02-16
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02241759. Inclusion in this directory is not an endorsement.